Clik here to view.
MANF Therapeutics Announces Issuance of Patent in Hong Kong Covering Use of...
NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – MANF Therapeutics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS) in pre-clinical development...
View ArticleClik here to view.
Amarantus Enters into Exclusive Option Agreement with Leipzig University to...
NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
View ArticleClik here to view.
Amarantus Provides Business Overview
NEW YORK, May 11, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
View ArticleClik here to view.
MANF Therapeutics Announces Publication in Society for Neuroscience eNeuro...
NEW YORK, May 21, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- MANF Therapeutics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS) in pre-clinical development...
View ArticleClik here to view.
Amarantus Retains Weild & Co. to Advise on JOBS Act Funding
Mr. Heng Fai Chan converts secured debt into common equity NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company," or AMBS), a...
View ArticleClik here to view.
Amarantus to Present at LD Micro and The Reg A Conference
NEW YORK, May 24, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTCPink:AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
View ArticleClik here to view.
Amarantus Exercises Exclusive Option with Leipzig University for Alzheimer's...
Scope of exercised Exclusive Option Agreement expanded to include negotiations for IP rights to additional key markers collected in German clinical study, including CSF-tau NEW YORK, May 30, 2018...
View ArticleClik here to view.
MANF Therapeutics Announces Publication of Positive Data for MANF in Stroke...
NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- MANF Therapeutics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS) in pre-clinical development...
View ArticleClik here to view.
Amarantus Provides Update on Elto Pharma Capital Formation Plan
NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company," or AMBS), a US-based, JLABS-alumnus biotechnology holding company...
View ArticleClik here to view.
MANF Therapeutics Announces Independent Publication of Positive Data for MANF...
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--MANF Therapeutics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS) in pre-clinical development...
View ArticleClik here to view.
MANF Therapeutics Announces Positive MANF Pre-Clinical Data inAlpha-Synuclein...
NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- MANF Therapeutics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS) in pre-clinical development...
View ArticleClik here to view.
Amarantus Provides Corporate Update
NEW YORK, July 20, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company...
View ArticleClik here to view.
Coeptis Pharma Enters into Agreement to Acquire Elto Pharma
NEW YORK and WEXFORD, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Coeptis Pharmaceuticals, Inc., a diversified commercial biopharmaceutical company, today announced that it has entered...
View ArticleClik here to view.
Amarantus Provides 2019 Roadmap
NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the "Company," or AMBS), a US-based, JLABS-alumnus biotechnology holding company...
View ArticleAmarantus Announces Commercialization Partnership With IDEA Pharma for...
NEW YORK, January 11, 2019 /PRNewswire/ -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company developing...
View ArticleClik here to view.
MANF Therapeutics Receives Notice of Allowance from US Patent & Trademark...
New York, NY, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MANF Therapeutics, a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK: AMBS) in pre-clinical development...
View ArticleClik here to view.
MANF Therapeutics Receives Notices of Allowance Covering MANF Use as...
New York, NY, Jan. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MANF Therapeutics, a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK: AMBS) in pre-clinical development...
View ArticleClik here to view.
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture...
JV to focus on the development of Alzheimer’s blood diagnostic LymPro Test 2.0 REHOVOT, Israel and NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage...
View ArticleClik here to view.
Amarantus Engages Evolution Venture Partners to Evaluate Strategic...
New York, NY, May 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding company...
View ArticleClik here to view.
Amarantus Releases Letter to Shareholders
New York, NY, May 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding company...
View Article